Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Omada Health (OMDA) to $20 from $25 and keeps an Outperform rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMDA:
- Omada Health price target lowered to $18 from $27 at BMO Capital
- Omada Health price target lowered to $30 from $32 at Morgan Stanley
- Omada Health price target lowered to $22 from $28 at Canaccord
- Omada Health price target raised to $18 from $17 at Barclays
- Omada Health announces GLP-1 Flex Care for employers